| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.3 | 0.03 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.12 | 0.03 |